Province Wide Rounds | Evolving Therapies to Treat Chronic Kidney Disease: SGLT2 Inhibitors, MRAs and Beyond

Event Details

About the Event

  • Describe the unmet need and residual risk of progression in CKD
  • Review benefits of SGLT2 inhibitors in CKD
  • Role of novel MRA treatment for CKD
  • Understand potential role for emerging therapies for CKD Time

To learn more, click here for the Island Health medical staff calendar.